Drug Naive Females Affected With Mild to Moderate Depressive Disorder Are At Higher Risk Of Having Sexual Dysfunction Than Those Treated With Escitalopram: A Comparative Prospective Study
Not Applicable
- Conditions
- urology
- Registration Number
- JPRN-UMIN000028117
- Lead Sponsor
- cairo university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
Any patient with severe depression indicated by a PHQ-9 score <10 was excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the Arabic validated version of the female sexual function index (ArFSFI), the Arabic version of the center for epidemiological studies-depression CES-D score as well as the Arabic version of perceived stress situation (PSS) score, and the Arabic version of the patient health questionnaire (PHQ-9) score. The husbands of the female participants were evaluated separately by the validated Arabic version of the international index of erectile function
- Secondary Outcome Measures
Name Time Method sexual functions in females with major depressive disorder receiving escitalopram